CN113425693A - 一种妇科泡腾片剂的配方及制作方法 - Google Patents
一种妇科泡腾片剂的配方及制作方法 Download PDFInfo
- Publication number
- CN113425693A CN113425693A CN202110745729.1A CN202110745729A CN113425693A CN 113425693 A CN113425693 A CN 113425693A CN 202110745729 A CN202110745729 A CN 202110745729A CN 113425693 A CN113425693 A CN 113425693A
- Authority
- CN
- China
- Prior art keywords
- parts
- gynecological
- effervescent tablet
- centipede
- borneol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000007938 effervescent tablet Substances 0.000 title claims abstract description 31
- 238000009472 formulation Methods 0.000 title claims description 5
- 238000002360 preparation method Methods 0.000 title abstract description 13
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims abstract description 54
- 238000007689 inspection Methods 0.000 claims abstract description 38
- 238000001514 detection method Methods 0.000 claims abstract description 36
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims abstract description 36
- 239000000047 product Substances 0.000 claims abstract description 20
- 239000000463 material Substances 0.000 claims abstract description 19
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 18
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 claims abstract description 18
- VAZJLPXFVQHDFB-UHFFFAOYSA-N 1-(diaminomethylidene)-2-hexylguanidine Polymers CCCCCCN=C(N)N=C(N)N VAZJLPXFVQHDFB-UHFFFAOYSA-N 0.000 claims abstract description 18
- 244000020518 Carthamus tinctorius Species 0.000 claims abstract description 18
- 241000258920 Chilopoda Species 0.000 claims abstract description 18
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 claims abstract description 18
- 229920001353 Dextrin Polymers 0.000 claims abstract description 18
- 239000004375 Dextrin Substances 0.000 claims abstract description 18
- 241000207925 Leonurus Species 0.000 claims abstract description 18
- 235000000802 Leonurus cardiaca ssp. villosus Nutrition 0.000 claims abstract description 18
- 229920002413 Polyhexanide Polymers 0.000 claims abstract description 18
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 claims abstract description 18
- 229920002472 Starch Polymers 0.000 claims abstract description 18
- 240000004824 Trimezia steyermarkii Species 0.000 claims abstract description 18
- 229940116229 borneol Drugs 0.000 claims abstract description 18
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 claims abstract description 18
- 235000019425 dextrin Nutrition 0.000 claims abstract description 18
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 claims abstract description 18
- 239000009136 dragon's blood Substances 0.000 claims abstract description 18
- 235000019359 magnesium stearate Nutrition 0.000 claims abstract description 18
- 239000008107 starch Substances 0.000 claims abstract description 18
- 235000019698 starch Nutrition 0.000 claims abstract description 18
- 235000003255 Carthamus tinctorius Nutrition 0.000 claims abstract description 15
- 239000002994 raw material Substances 0.000 claims abstract description 13
- 241000334160 Isatis Species 0.000 claims abstract description 12
- 238000004806 packaging method and process Methods 0.000 claims abstract description 12
- 239000000843 powder Substances 0.000 claims abstract description 12
- 239000011265 semifinished product Substances 0.000 claims abstract description 11
- 239000010231 banlangen Substances 0.000 claims abstract description 6
- 235000015165 citric acid Nutrition 0.000 claims abstract description 6
- 238000007873 sieving Methods 0.000 claims abstract description 6
- 230000001953 sensory effect Effects 0.000 claims description 10
- 241000218691 Cupressaceae Species 0.000 claims description 9
- 241000212948 Cnidium Species 0.000 claims description 6
- 235000013399 edible fruits Nutrition 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 4
- 244000005700 microbiome Species 0.000 claims description 2
- 244000052769 pathogen Species 0.000 claims 1
- 230000001717 pathogenic effect Effects 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 3
- 239000003814 drug Substances 0.000 abstract description 2
- 231100000331 toxic Toxicity 0.000 abstract description 2
- 230000002588 toxic effect Effects 0.000 abstract description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 6
- 244000052616 bacterial pathogen Species 0.000 description 4
- 230000000813 microbial effect Effects 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 208000007074 Trichomonas Vaginitis Diseases 0.000 description 1
- 208000025206 Trichomonas vaginitis urogenital infection Diseases 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 229940095731 candida albicans Drugs 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000003670 easy-to-clean Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 210000001215 vagina Anatomy 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/648—Myriapods, e.g. centipedes or millipedes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/19—Acanthaceae (Acanthus family)
- A61K36/195—Strobilanthes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/234—Cnidium (snowparsley)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
- A61K36/315—Isatis, e.g. Dyer's woad
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/489—Sophora, e.g. necklacepod or mamani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/533—Leonurus (motherwort)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/756—Phellodendron, e.g. corktree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0007—Effervescent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Insects & Arthropods (AREA)
- Gynecology & Obstetrics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Medicinal Preparation (AREA)
Abstract
本发明涉及一种妇科泡腾片剂的配方及制作方法,包括以下重量份的原料:苦参90‑110份,黄柏70‑90份,蛇床子50‑70份,红花30‑50份,蜈蚣15‑25份,益母草30‑50份,血竭20‑30份,板蓝根20‑30份,冰片4‑6份,聚六亚甲基双胍0.03份、柠檬酸17.2份,碳酸氢钠15.5份、糊精10份、淀粉15.8份、硬脂酸镁1份。一种妇科泡腾片剂的制作方法,包括以下步骤:将苦参、黄柏、蛇床子、红花、蜈蚣、益母草、血竭、板蓝根、冰片粉碎过100目制备成药材细粉37.5份,再加入聚六亚甲基双胍、柠檬酸,碳酸氢钠、糊精、淀粉、硬脂酸镁,后混合30分钟,再依次进行压片、半成品检测、内包装、外包装、成品检验、入库。本发明优点:组方配伍合理,制作方便,毒副作用小,使用方便,治愈时间短,治愈后不易复发。
Description
技术领域
本发明涉及消毒抗(抑)菌产品领域,具体是指一种妇科泡腾片剂的配方及制作方法。
背景技术
现有的液体妇科抗抑菌剂大多数为洗液,使用不方便,携带不便,且抗菌抑菌效果不甚理想,不能满足使用者的护理需要,如何提供一种制作使用方便,抑菌抗菌效果好的妇科泡腾片剂的配方及制作方法成为研究方向。
发明内容
本发明的目的在于提供一种妇科泡腾片剂的配方及制作方法,以解决上述背景技术中提出的问题。
为解决上述技术问题,本发明提供的技术方案为:一种妇科泡腾片剂的配方,包括以下重量份的原料:苦参90-110份,黄柏70-90份,蛇床子50-70份,红花30-50份,蜈蚣15-25份,益母草30-50份,血竭20-30份,板蓝根20-30份,冰片4-6份,聚六亚甲基双胍0.03份、柠檬酸17.2份,碳酸氢钠15.5份、糊精10份、淀粉15.8份、硬脂酸镁1份。
作为一种优选方案,一种妇科泡腾片剂的配方,包括以下重量份的原料:苦参100份,黄柏80份,蛇床子60份,红花40份,蜈蚣20份,益母草40份,血竭25份,板蓝根25份,冰片5份,聚六亚甲基双胍0.03份、柠檬酸17.2份,碳酸氢钠15.5份、糊精10份、淀粉15.8份、硬脂酸镁1份。
作为一种优选方案,一种妇科泡腾片剂的配方,包括以下重量份的原料:苦参90份,黄柏90份,蛇床子50份,红花50份,蜈蚣15份,益母草50份,血竭20份,板蓝根30份,冰片4份,聚六亚甲基双胍0.03份、柠檬酸17.2份,碳酸氢钠15.5份、糊精10份、淀粉15.8份、硬脂酸镁1份。
作为一种优选方案,一种妇科泡腾片剂的配方,包括以下重量份的原料:苦参110份,黄柏70份,蛇床子70份,红花30份,蜈蚣25份,益母草30份,血竭30份,板蓝根20份,冰片6份,聚六亚甲基双胍0.03份、柠檬酸17.2份,碳酸氢钠15.5份、糊精10份、淀粉15.8份、硬脂酸镁1份。
一种妇科泡腾片剂的制作方法,采用上述妇科泡腾片剂的配方,包括以下步骤:将苦参、黄柏、蛇床子、红花、蜈蚣、益母草、血竭、板蓝根、冰片粉碎过100目制备成药材细粉37.5份,再加入聚六亚甲基双胍、柠檬酸,碳酸氢钠、糊精、淀粉、硬脂酸镁,后混合30分钟,再依次进行压片、半成品检测、内包装、外包装、成品检验、入库。
作为优选,所述半成品检测包括感官检测、重量差异检测、pH值检测、崩解时限检测、含量检测。
作为优选,所述成品检验包括感官检测、重量差异检测、pH值检测、崩解时限检测、含量检测、微生物限度、致病菌检验。
本发明优点在于:组方配伍合理,制作方便,且具有携带和使用方便的特点,能明显减少阴道致病微生物的数量,降低感染机会,对常见微生物所引起的细菌性、霉菌性、滴虫性阴道炎有较突出的疗效,且安全,毒副作用小,使用方便,治愈时间短,治愈后不易复发,具有很好的推广前景和市场价值。
附图说明
图1是本发明的工艺流程图。
具体实施方式
下面用具体实施例说明本发明,并不是对本发明的限制。
实施例1
一种妇科泡腾片剂的配方,包括以下重量份的原料:苦参100份,黄柏80份,蛇床子60份,红花40份,蜈蚣20份,益母草40份,血竭25份,板蓝根25份,冰片5份,聚六亚甲基双胍0.03份、柠檬酸17.2份,碳酸氢钠15.5份、糊精10份、淀粉15.8份、硬脂酸镁1份。
一种妇科泡腾片剂的制作方法,采用上述妇科泡腾片剂的配方,包括以下步骤:将苦参、黄柏、蛇床子、红花、蜈蚣、益母草、血竭、板蓝根、冰片粉碎过100目制备成药材细粉37.5份,再加入聚六亚甲基双胍、柠檬酸,碳酸氢钠、糊精、淀粉、硬脂酸镁,后混合30分钟,再依次进行压片、半成品检测、内包装、外包装、成品检验、入库。
作为本实施例的优选实施方式,所述半成品检测包括感官检测、重量差异检测、pH值检测、崩解时限检测、含量检测。
作为本实施例的优选实施方式,所述成品检验包括感官检测、重量差异检测、pH值检测、崩解时限检测、含量检测、微生物限度、致病菌检验。
实施例2
一种妇科泡腾片剂的配方,包括以下重量份的原料:苦参90份,黄柏90份,蛇床子50份,红花50份,蜈蚣15份,益母草50份,血竭20份,板蓝根30份,冰片4份,聚六亚甲基双胍0.03份、柠檬酸17.2份,碳酸氢钠15.5份、糊精10份、淀粉15.8份、硬脂酸镁1份。
一种妇科泡腾片剂的制作方法,采用上述妇科泡腾片剂的配方,包括以下步骤:将苦参、黄柏、蛇床子、红花、蜈蚣、益母草、血竭、板蓝根、冰片粉碎过100目制备成药材细粉37.5份,再加入聚六亚甲基双胍、柠檬酸,碳酸氢钠、糊精、淀粉、硬脂酸镁,后混合30分钟,再依次进行压片、半成品检测、内包装、外包装、成品检验、入库。
作为本实施例的优选实施方式,所述半成品检测包括感官检测、重量差异检测、pH值检测、崩解时限检测、含量检测。
作为本实施例的优选实施方式,所述成品检验包括感官检测、重量差异检测、pH值检测、崩解时限检测、含量检测、微生物限度、致病菌检验。
实施例3
一种妇科泡腾片剂的配方,包括以下重量份的原料:苦参110份,黄柏70份,蛇床子70份,红花30份,蜈蚣25份,益母草30份,血竭30份,板蓝根20份,冰片6份,聚六亚甲基双胍0.03份、柠檬酸17.2份,碳酸氢钠15.5份、糊精10份、淀粉15.8份、硬脂酸镁1份。
一种妇科泡腾片剂的制作方法,采用上述妇科泡腾片剂的配方,包括以下步骤:将苦参、黄柏、蛇床子、红花、蜈蚣、益母草、血竭、板蓝根、冰片粉碎过100目制备成药材细粉37.5份,再加入聚六亚甲基双胍、柠檬酸,碳酸氢钠、糊精、淀粉、硬脂酸镁,后混合30分钟,再依次进行压片、半成品检测、内包装、外包装、成品检验、入库。
作为本实施例的优选实施方式,所述半成品检测包括感官检测、重量差异检测、pH值检测、崩解时限检测、含量检测。
作为本实施例的优选实施方式,所述成品检验包括感官检测、重量差异检测、pH值检测、崩解时限检测、含量检测、微生物限度、致病菌检验。
本发明组方配伍合理,使用本产品5分钟对金黄色葡萄球菌平均抑菌率达50%以上(抑菌产品标准50%为合格,实际也可达到90%以上);使用本产品5分钟对白色念珠菌平均抑菌率达50%以上(抑菌产品标准50%为合格,实际也可达到90%以上);使用本产品5分钟对大肠杆菌平均抑菌率达50%以上(抑菌产品标准50%为合格,实际也可达到90%以上)。
环境要求:通风性好,排风设施完善,车间墙壁,顶棚,门窗等采用防易清洗,防火,防静电,生产车间内洁净级别控制在30万级以上。
设备要求:设备材质耐腐蚀、易清洁消毒。
原料要求:中药材符合中国药典一部所规定内容。
以上所述,仅为本发明较佳的具体实施方式,但本发明的保护范围并不局限于此,任何熟悉本技术领域的技术人员在本发明揭露的技术范围内,根据本发明的技术方案及其发明构思加以等同替换或改变,都应涵盖在本发明的保护范围之内。
Claims (7)
1.一种妇科泡腾片剂的配方,其特征在于,包括以下重量份的原料:苦参90-110份,黄柏70-90份,蛇床子50-70份,红花30-50份,蜈蚣15-25份,益母草30-50份,血竭20-30份,板蓝根20-30份,冰片4-6份,聚六亚甲基双胍0.03份、柠檬酸17.2份,碳酸氢钠15.5份、糊精10份、淀粉15.8份、硬脂酸镁1份。
2.根据权利要求1所述的一种妇科泡腾片剂的配方,其特征在于,包括以下重量份的原料:苦参100份,黄柏80份,蛇床子60份,红花40份,蜈蚣20份,益母草40份,血竭25份,板蓝根25份,冰片5份,聚六亚甲基双胍0.03份、柠檬酸17.2份,碳酸氢钠15.5份、糊精10份、淀粉15.8份、硬脂酸镁1份。
3.根据权利要求1所述的一种妇科泡腾片剂的配方,其特征在于,包括以下重量份的原料:苦参90份,黄柏90份,蛇床子50份,红花50份,蜈蚣15份,益母草50份,血竭20份,板蓝根30份,冰片4份,聚六亚甲基双胍0.03份、柠檬酸17.2份,碳酸氢钠15.5份、糊精10份、淀粉15.8份、硬脂酸镁1份。
4.根据权利要求1所述的一种妇科泡腾片剂的配方,其特征在于,包括以下重量份的原料:苦参110份,黄柏70份,蛇床子70份,红花30份,蜈蚣25份,益母草30份,血竭30份,板蓝根20份,冰片6份,聚六亚甲基双胍0.03份、柠檬酸17.2份,碳酸氢钠15.5份、糊精10份、淀粉15.8份、硬脂酸镁1份。
5.一种妇科泡腾片剂的制作方法,采用权利要求1-4任一项所述的一种妇科泡腾片剂的配方,其特征在于,包括以下步骤:将苦参、黄柏、蛇床子、红花、蜈蚣、益母草、血竭、板蓝根、冰片粉碎过100目制备成药材细粉37.5份,再加入聚六亚甲基双胍、柠檬酸,碳酸氢钠、糊精、淀粉、硬脂酸镁,后混合30分钟,再依次进行压片、半成品检测、内包装、外包装、成品检验、入库。
6.根据权利要求5所述的一种妇科泡腾片剂的制作方法,其特征在于,所述半成品检测包括感官检测、重量差异检测、pH值检测、崩解时限检测、含量检测。
7.根据权利要求5所述的一种妇科泡腾片剂的制作方法,其特征在于,所述成品检验包括感官检测、重量差异检测、pH值检测、崩解时限检测、含量检测、微生物限度、致病菌检验。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110745729.1A CN113425693A (zh) | 2021-07-01 | 2021-07-01 | 一种妇科泡腾片剂的配方及制作方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110745729.1A CN113425693A (zh) | 2021-07-01 | 2021-07-01 | 一种妇科泡腾片剂的配方及制作方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN113425693A true CN113425693A (zh) | 2021-09-24 |
Family
ID=77758479
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110745729.1A Pending CN113425693A (zh) | 2021-07-01 | 2021-07-01 | 一种妇科泡腾片剂的配方及制作方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113425693A (zh) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1895602A (zh) * | 2006-06-23 | 2007-01-17 | 范十足 | 一种防治妇科疾病的女性外用泡腾片 |
CN104663737A (zh) * | 2014-05-27 | 2015-06-03 | 陕西仁康药业有限公司 | 一种清菌泡腾片配方及其制备方法 |
CN105709001A (zh) * | 2016-04-07 | 2016-06-29 | 甘起伍 | 抗菌泡腾片及其制备方法 |
CN107875264A (zh) * | 2017-11-21 | 2018-04-06 | 佛山微赢电子商务有限公司 | 一种私处护理抑菌凝胶及其制备方法 |
CN111068016A (zh) * | 2020-01-17 | 2020-04-28 | 璧典附 | 一种苦参私密护理抑菌凝胶及其制备方法 |
-
2021
- 2021-07-01 CN CN202110745729.1A patent/CN113425693A/zh active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1895602A (zh) * | 2006-06-23 | 2007-01-17 | 范十足 | 一种防治妇科疾病的女性外用泡腾片 |
CN104663737A (zh) * | 2014-05-27 | 2015-06-03 | 陕西仁康药业有限公司 | 一种清菌泡腾片配方及其制备方法 |
CN105709001A (zh) * | 2016-04-07 | 2016-06-29 | 甘起伍 | 抗菌泡腾片及其制备方法 |
CN107875264A (zh) * | 2017-11-21 | 2018-04-06 | 佛山微赢电子商务有限公司 | 一种私处护理抑菌凝胶及其制备方法 |
CN111068016A (zh) * | 2020-01-17 | 2020-04-28 | 璧典附 | 一种苦参私密护理抑菌凝胶及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103285028B (zh) | 一种壳聚糖和有机硅季铵盐复合抗菌剂及制备方法 | |
CN105670092A (zh) | 一种ldpe抗菌塑料及其制备方法 | |
CN103098795B (zh) | 一种银离子杀菌分散片及其制备工艺和在清洁果蔬残留细菌中的应用 | |
CN105694229A (zh) | 一种pp抗菌塑料及其制备方法 | |
CN101791319A (zh) | 女性阴部护理品 | |
CN103548907A (zh) | 一种本草中药抗菌组合物及中药抗菌滤网 | |
CN101218924A (zh) | 防治水稻纹枯病的多粘类芽孢杆菌与井冈霉素组合物 | |
CN113425693A (zh) | 一种妇科泡腾片剂的配方及制作方法 | |
CN103493849A (zh) | 一种玫瑰精油消毒凝胶 | |
CN105476920A (zh) | 一种中药洗手液 | |
CN204951354U (zh) | 一种纸尿裤 | |
CN113499403A (zh) | 一种妇科中药护垫的配方及制作方法 | |
CN107568265A (zh) | 一种塑料用银‑稀土复合抗菌剂 | |
CN103518786A (zh) | 一种有效杀灭金黄色葡萄球菌的茉莉精油复合消毒液 | |
CN111249413A (zh) | 一种五合一私密抑菌凝胶及其制备方法 | |
CN107412122A (zh) | 一种纯天然口腔护理液 | |
CN104904753A (zh) | 高效消毒剂及其制备方法 | |
CN104996503A (zh) | 一种用于养殖场的中药复方空气消毒喷雾剂及其制备方法 | |
CN103555036A (zh) | 一种银离子抗菌胶及其制备方法 | |
CN113521146A (zh) | 一种液体妇科抗菌剂的配方及制作方法 | |
CN106420938A (zh) | 一种治疗口腔炎症及咽炎的中药组合物及其制备方法 | |
CN1480187A (zh) | 一种治疗黄水疮的药物 | |
CN105477589A (zh) | 外科手术前消毒的药物及制备方法 | |
CN206556143U (zh) | 一种消除雾霾及杀菌的窗式空气净化装置 | |
CN105623165A (zh) | 一种用于妇科医用垫的银离子抗菌试剂及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210924 |
|
RJ01 | Rejection of invention patent application after publication |